Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Petrini

Showing results (1-10 of 254) with videos related to

Pageof 26
Sort By:
Current Opinion in Hematology|November 30, 2011
Lithium in the treatment of neutropeniaMario Petrini, Antonio Azzarà
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2007
CD57 expression on lymphoma microenvironment as a new prognostic marker related to immune dysfunctionDaniele Focosi, Mario Petrini
The New England Journal of Medicine|July 14, 2006
More on donor-derived T-cell leukemia after bone marrow transplantationDaniele Focosi, Mario Petrini
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
Comment on "Germinal center helper T cells are dual functional regulatory cells with suppressive activity to conventional CD4+ T cells"Daniele Focosi, Mario Petrini
Frontiers in Cell and Developmental Biology|June 15, 2017
Editorial: In Search of <i>In vivo</i> MSCSimone Pacini, Mario Petrini
Current Treatment Options in Oncology|October 11, 2007
Hairy Cell LeukemiaRossella Riccioni, Sara Galimberti, Mario Petrini
British Journal of Haematology|October 9, 2003
Lithium effects on neutrophil motility in Shwachman-Diamond syndrome: evaluation by computer-assisted image analysisAntonio Azzarà, Giovanni Carulli, Mario Petrini
Leukemia Research|October 19, 2006
Bortezomib inhibits T-cell function versus infective antigenic stimuli in a dose-dependent manner in vitroEnrico Orciuolo, Sara Galimberti, Mario Petrini
Haematologica|September 5, 2007
Acute myeloid leukemia and follicular lymphoma after very low dose radioiodine therapy for thyroid diseasesDaniele Focosi, Sara Galimberti, Mario Petrini
Lancet (London, England)|January 30, 2007
GliptinsDaniele Focosi, Richard Eric Kast, Mario Petrini
Pageof 26

Showing results (1-10 of 254) with videos related to

Sort By:
Pageof 26
Current Opinion in Hematology|November 30, 2011
Lithium in the treatment of neutropeniaMario Petrini, Antonio Azzarà
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2007
CD57 expression on lymphoma microenvironment as a new prognostic marker related to immune dysfunctionDaniele Focosi, Mario Petrini
The New England Journal of Medicine|July 14, 2006
More on donor-derived T-cell leukemia after bone marrow transplantationDaniele Focosi, Mario Petrini
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
Comment on "Germinal center helper T cells are dual functional regulatory cells with suppressive activity to conventional CD4+ T cells"Daniele Focosi, Mario Petrini
Frontiers in Cell and Developmental Biology|June 15, 2017
Editorial: In Search of <i>In vivo</i> MSCSimone Pacini, Mario Petrini
Current Treatment Options in Oncology|October 11, 2007
Hairy Cell LeukemiaRossella Riccioni, Sara Galimberti, Mario Petrini
British Journal of Haematology|October 9, 2003
Lithium effects on neutrophil motility in Shwachman-Diamond syndrome: evaluation by computer-assisted image analysisAntonio Azzarà, Giovanni Carulli, Mario Petrini
Leukemia Research|October 19, 2006
Bortezomib inhibits T-cell function versus infective antigenic stimuli in a dose-dependent manner in vitroEnrico Orciuolo, Sara Galimberti, Mario Petrini
Haematologica|September 5, 2007
Acute myeloid leukemia and follicular lymphoma after very low dose radioiodine therapy for thyroid diseasesDaniele Focosi, Sara Galimberti, Mario Petrini
Lancet (London, England)|January 30, 2007
GliptinsDaniele Focosi, Richard Eric Kast, Mario Petrini
Pageof 26